The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

被引:80
作者
Boyle, Eileen M. [1 ,2 ,3 ]
Deshpande, Shayu [1 ]
Tytarenko, Ruslana [1 ]
Ashby, Cody [1 ,4 ]
Wang, Yan [1 ]
Bauer, Michael A. [1 ,4 ]
Johnson, Sarah K. [1 ]
Wardell, Christopher P. [1 ,4 ]
Thanendrarajan, Sharmilan [1 ]
Zangari, Maurizio [1 ]
Facon, Thierry [5 ]
Dumontet, Charles [2 ]
Barlogie, Bart [6 ]
Arbini, Arnaldo [3 ]
Rustad, Even H. [3 ]
Maura, Francesco [7 ]
Landgren, Ola [7 ]
Zhan, Fenghuang [1 ]
van Rhee, Frits [1 ]
Schinke, Carolina [1 ]
Davies, Faith E. [3 ]
Morgan, Gareth J. [3 ]
Walker, Brian A. [8 ]
机构
[1] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA
[2] Canc Res Ctr Lyon, INSERM 1052, CNRS 5286, Lyon, France
[3] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY 10016 USA
[4] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA
[5] Lille Univ Hosp, Serv Malad Sang, Hop Claude Huriez, Lille, France
[6] Mt Sinai Hosp, Div Hematol, New York, NY 10029 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA
[8] Indiana Univ, Div Hematol Oncol, Indianapolis, IN 46204 USA
关键词
COPY NUMBER; PROGRESSION; RISK; LESIONS; ABNORMALITIES; PREDICT; MODEL;
D O I
10.1038/s41467-020-20524-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Smoldering myeloma (SMM) is associated with a high-risk of progression to myeloma (MM). We report the results of a study of 82 patients with both targeted sequencing that included a capture of the immunoglobulin and MYC regions. By comparing these results to newly diagnosed myeloma (MM) we show fewer NRAS and FAM46C mutations together with fewer adverse translocations, del(1p), del(14q), del(16q), and del(17p) in SMM consistent with their role as drivers of the transition to MM. KRAS mutations are associated with a shorter time to progression (HR 3.5 (1.5-8.1), p = 0.001). In an analysis of change in clonal structure over time we studied 53 samples from nine patients at multiple time points. Branching evolutionary patterns, novel mutations, biallelic hits in crucial tumour suppressor genes, and segmental copy number changes are key mechanisms underlying the transition to MM, which can precede progression and be used to guide early intervention strategies.
引用
收藏
页数:13
相关论文
共 39 条
[1]   The repertoire of mutational signatures in human cancer [J].
Alexandrov, Ludmil B. ;
Kim, Jaegil ;
Haradhvala, Nicholas J. ;
Huang, Mi Ni ;
Ng, Alvin Wei Tian ;
Wu, Yang ;
Boot, Arnoud ;
Covington, Kyle R. ;
Gordenin, Dmitry A. ;
Bergstrom, Erik N. ;
Islam, S. M. Ashiqul ;
Lopez-Bigas, Nuria ;
Klimczak, Leszek J. ;
McPherson, John R. ;
Morganella, Sandro ;
Sabarinathan, Radhakrishnan ;
Wheeler, David A. ;
Mustonen, Ville ;
Getz, Gad ;
Rozen, Steven G. ;
Stratton, Michael R. .
NATURE, 2020, 578 (7793) :94-+
[2]  
Allaby M., 2009, A Dictionary of Zoology, V3rd
[3]   Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].
Annunziata, Christina M. ;
Davis, R. Eric ;
Demchenko, Yulia ;
Bellamy, William ;
Gabrea, Ana ;
Zhan, Fenghuang ;
Lenz, Georg ;
Hanamura, Ichiro ;
Wright, George ;
Xiao, Wenming ;
Dave, Sandeep ;
Hurt, Elaine M. ;
Tan, Bruce ;
Zhao, Hong ;
Stephens, Owen ;
Santra, Madhumita ;
Williams, David R. ;
Dang, Lenny ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. ;
Kuehl, W. Michael ;
Staudt, Louis M. .
CANCER CELL, 2007, 12 (02) :115-130
[4]  
[Anonymous], 2020, GCRMA BACKGROUND ADJ
[5]   TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use [J].
Ashby, Cody ;
Rutherford, Michael ;
Bauer, Michael A. ;
Peterson, Erich A. ;
Wang, Yan ;
Boyle, Eileen M. ;
Wardell, Christopher P. ;
Walker, Brian A. .
BMC BIOINFORMATICS, 2020, 21 (01)
[6]   A continuum model for tumour suppression [J].
Berger, Alice H. ;
Knudson, Alfred G. ;
Pandolfi, Pier Paolo .
NATURE, 2011, 476 (7359) :163-169
[7]   Genomic patterns of progression in smoldering multiple myeloma [J].
Bolli, Niccolo ;
Maura, Francesco ;
Minvielle, Stephane ;
Gloznik, Dominik ;
Szalat, Raphael ;
Fullam, Anthony ;
Martincorena, Inigo ;
Dawson, Kevin J. ;
Samur, Mehmet Kemal ;
Zamora, Jorge ;
Tarpey, Patrick ;
Davies, Helen ;
Fulciniti, Mariateresa ;
Shammas, Masood A. ;
Tai, Yu Tzu ;
Magrangeas, Florence ;
Moreau, Philippe ;
Corradini, Paolo ;
Anderson, Kenneth ;
Alexandrov, Ludmil ;
Wedge, David C. ;
Avet-Loiseau, Herve ;
Campbell, Peter ;
Munshi, Nikhil .
NATURE COMMUNICATIONS, 2018, 9
[8]   A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial [J].
Boyd, K. D. ;
Ross, F. M. ;
Chiecchio, L. ;
Dagrada, G. P. ;
Konn, Z. J. ;
Tapper, W. J. ;
Walker, B. A. ;
Wardell, C. P. ;
Gregory, W. M. ;
Szubert, A. J. ;
Bell, S. E. ;
Child, J. A. ;
Jackson, G. H. ;
Davies, F. E. ;
Morgan, G. J. .
LEUKEMIA, 2012, 26 (02) :349-355
[9]   BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma [J].
Boyle, Eileen M. ;
Ashby, Cody ;
Tytarenko, Ruslana G. ;
Deshpande, Shayu ;
Wang, Hongwei ;
Wang, Yan ;
Rosenthal, Adam ;
Sawyer, Jeffrey ;
Tian, Erming ;
Flynt, Erin ;
Hoering, Antje ;
Johnson, Sarah K. ;
Rutherford, Michael W. ;
Wardell, Christopher P. ;
Bauer, Michael A. ;
Dumontet, Charles ;
Facon, Thierry ;
Thanendrarajan, Sharmilan ;
Schinke, Carolina D. ;
Zangari, Maurizio ;
van Rhee, Frits ;
Barlogie, Bart ;
Cairns, David ;
Jackson, Graham ;
Thakurta, Anjan ;
Davies, Faith E. ;
Morgan, Gareth J. ;
Walker, Brian A. .
CLINICAL CANCER RESEARCH, 2020, 26 (10) :2422-2432
[10]   Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression [J].
Bustoros, Mark ;
Sklavenitis-Pistofidis, Romanos ;
Park, Jihye ;
Redd, Robert ;
Zhitomirsky, Benny ;
Dunford, Andrew J. ;
Salem, Karma ;
Tai, Yu-Tzu ;
Anand, Shankara ;
Mouhieddine, Tarek H. ;
Chavda, Selina J. ;
Boehner, Cody ;
Elagina, Liudmila ;
Neuse, Carl Jannes ;
Cha, Justin ;
Rahmat, Mahshid ;
Taylor-Weiner, Amaro ;
Van Allen, Eliezer ;
Kumar, Shaji ;
Kastritis, Efstathis ;
Leshchiner, Ignaty ;
Morgan, Elizabeth A. ;
Laubach, Jacob ;
Casneuf, Tineke ;
Richardson, Paul ;
Munshi, Nikhil C. ;
Anderson, Kenneth C. ;
Trippa, Lorenzo ;
Aguet, Francois ;
Stewart, Chip ;
Dimopoulos, Meletios-Athanasios ;
Yong, Kwee ;
Bergsagel, P. Leif ;
Manier, Salomon ;
Getz, Gad ;
Ghobrial, Irene M. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (21) :2380-+